Scholarlink

<p>One of the most common genetic risk factors for Parkinson’s disease (PD) is variants in <i>GBA1</i>, which encodes the lysosomal enzyme glucocerebrosidase (GCase). GCase deficiency has been associated with an increased PD risk, but not all individuals with low GCase activity are carriers of <i>GBA1</i> mutations, suggesting other factors may be acting as modifiers. We aimed to discover common variants associated with GCase activity, as well as replicate previously reported associations, by performing a genome-wide association study using two independent cohorts: a Columbia University cohort consisting of 697 PD cases and 347 controls and the Parkinson’s Progression Markers Initiative (PPMI) cohort consisting of 357 PD cases and 163 controls. As expected, <i>GBA1</i> variants have the strongest association with decreased activity, led by N370S (beta =  − 4.36, se = 0.32, <i>p</i> = 5.05e − 43). We also identify a novel association in the <i>GAA</i> locus (encoding for acid alpha-glucosidase, beta =  − 0.96, se = 0.17, <i>p</i> = 5.23e − 09) that may be the result of an interaction between GCase and acid alpha-glucosidase based on various interaction analyses. Lastly, we show that several PD-risk loci are potentially associated with GCase activity. Further research will be needed to replicate and validate our findings and to uncover the functional connection between acid alpha-glucosidase and GCase.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月29日

查看全文
  • Emma N. Somerville,
  • Lynne Krohn,
  • Konstantin Senkevich,
  • Eric Yu,
  • Jamil Ahmad,
  • Farnaz Asayesh,
  • Jennifer A. Ruskey,
  • Dan Spiegelman,
  • Stanley Fahn,
  • Cheryl Waters,
  • S. Pablo Sardi,
  • Roy N. Alcalay,
  • Ziv Gan-Or

摘要

One of the most common genetic risk factors for Parkinson’s disease (PD) is variants in GBA1, which encodes the lysosomal enzyme glucocerebrosidase (GCase). GCase deficiency has been associated with an increased PD risk, but not all individuals with low GCase activity are carriers of GBA1 mutations, suggesting other factors may be acting as modifiers. We aimed to discover common variants associated with GCase activity, as well as replicate previously reported associations, by performing a genome-wide association study using two independent cohorts: a Columbia University cohort consisting of 697 PD cases and 347 controls and the Parkinson’s Progression Markers Initiative (PPMI) cohort consisting of 357 PD cases and 163 controls. As expected, GBA1 variants have the strongest association with decreased activity, led by N370S (beta =  − 4.36, se = 0.32, p = 5.05e − 43). We also identify a novel association in the GAA locus (encoding for acid alpha-glucosidase, beta =  − 0.96, se = 0.17, p = 5.23e − 09) that may be the result of an interaction between GCase and acid alpha-glucosidase based on various interaction analyses. Lastly, we show that several PD-risk loci are potentially associated with GCase activity. Further research will be needed to replicate and validate our findings and to uncover the functional connection between acid alpha-glucosidase and GCase.